SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-324529
Filing Date
2021-11-09
Accepted
2021-11-09 16:31:19
Documents
14
Period of Report
2021-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d322459d8k.htm   iXBRL 8-K 26638
2 EX-99.1 d322459dex991.htm EX-99.1 46339
6 GRAPHIC g322459g1109002232067.jpg GRAPHIC 4036
  Complete submission text file 0001193125-21-324529.txt   209169

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cala-20211109.xsd EX-101.SCH 2895
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cala-20211109_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cala-20211109_pre.xml EX-101.PRE 11410
7 EXTRACTED XBRL INSTANCE DOCUMENT d322459d8k_htm.xml XML 3366
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36644 | Film No.: 211392720
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences